GHK-Cu vs GLOW
Updated 8 sources
Key differences
- 1GLOW adds BPC-157 and TB-500 to 50 mg of GHK-Cu at a fixed ratio.
- 2For skin-only goals, topical GHK-Cu is where the human evidence is.
- 3GLOW adds repair peptides at a fixed ratio.
- 4For skin-only goals, topical GHK-Cu has the most human evidence.
Side by side
Facts from each record, in the same words as their own pages.
| GHK-Cu | GLOW | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
8 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study1
- He L et al. 2022, pharmacokinetics of BPC-157 in rats and dogs, Front PharmacolPubMed · checked Oct 23, 2026
Regulatory2
- FDA to remove 12 peptides from Category 2Frier Levitt · checked Oct 23, 2026
- FDA panel votes to loosen restrictions for four peptidesPharmExec, via a news report · checked Oct 23, 2026
Vendor guide1
- GHK-Cu beyond cosmetic hype (pharmacist review, 2026-02-11)Fagron Academy · checked Oct 23, 2026
Competitor guide4
- GLOW stackpeptidedosingprotocols.com · checked Oct 23, 2026
- GLOW blend compound pagebodyhackguide.co · checked Oct 23, 2026
- GHK-Cu half-life and shelf lifepeptidedeck.com · checked Oct 23, 2026
- Wolverine stack dosage chart (thymosin beta-4 IV half-life citation)peptidedeck.com · checked Oct 23, 2026